Ceftriaxone Treatment Guidelines for Respiratory Infections

Introduction to Ceftriaxone Treatment

The American Academy of Otolaryngology-Head and Neck Surgery recommends ceftriaxone 1-2 g/day for 5 days for moderate acute bacterial rhinosinusitis or treatment failures 4
The European Respiratory Journal suggests an initial IV ceftriaxone dose of 1-2 g every 24 hours for respiratory infections 2

For community-acquired pneumonia, the total treatment duration with ceftriaxone should be 5-7 days for uncomplicated cases, with IV therapy typically switched to oral antibiotics after 48-72 hours once clinical improvement is documented, as recommended by the American College of Physicians 1
The treatment duration can be extended to 10-14 days if specific pathogens are confirmed or suspected, including Staphylococcus aureus, gram-negative enteric bacilli, or Legionella, according to the American College of Physicians 1
Transition to oral antibiotics can occur after 48-72 hours when the patient meets specific criteria, such as temperature <38°C, improvement in cough and dyspnea, and adequate gastrointestinal function, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2

For pediatric patients with acute otitis media who have failed initial oral therapy, ceftriaxone can be administered at a dose of 50 mg/kg/day for 3-5 days, as recommended by the American Academy of Pediatrics 5
The American Academy of Otolaryngology-Head and Neck Surgery recommends reassessing patients with acute bacterial rhinosinusitis at 72 hours and considering alternative diagnoses or complications if there is no improvement 4